Search

Nancy Bitar

Examiner (ID: 18935, Phone: (571)270-1041 , Office: P/2669 )

Most Active Art Unit
2664
Art Unit(s)
2624, 2669, 2664
Total Applications
1257
Issued Applications
1017
Pending Applications
63
Abandoned Applications
197

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9401454 [patent_doc_number] => 08691506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds' [patent_app_type] => utility [patent_app_number] => 11/911222 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18823 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 227 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11911222 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/911222
Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds Apr 12, 2006 Issued
Array ( [id] => 5852023 [patent_doc_number] => 20060235214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Identification of cancer genes using a high-throughput forward genetic screening method' [patent_app_type] => utility [patent_app_number] => 11/400132 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2108 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235214.pdf [firstpage_image] =>[orig_patent_app_number] => 11400132 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/400132
Identification of cancer genes using a high-throughput forward genetic screening method Apr 6, 2006 Abandoned
Array ( [id] => 11231265 [patent_doc_number] => 09458487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Expression of mammalian proteins in pseudomonas fluorescens' [patent_app_type] => utility [patent_app_number] => 11/400840 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25411 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11400840 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/400840
Expression of mammalian proteins in pseudomonas fluorescens Apr 6, 2006 Issued
Array ( [id] => 5625304 [patent_doc_number] => 20060263809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Method for sensitive measure of low level apoptosis in cells' [patent_app_type] => utility [patent_app_number] => 11/399120 [patent_app_country] => US [patent_app_date] => 2006-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10440 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263809.pdf [firstpage_image] =>[orig_patent_app_number] => 11399120 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/399120
Method for sensitive measure of low level apoptosis in cells Apr 4, 2006 Abandoned
Array ( [id] => 9703665 [patent_doc_number] => 08828726 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Circular nucleic acid vectors, and methods for making and using the same' [patent_app_type] => utility [patent_app_number] => 11/398490 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 11299 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11398490 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/398490
Circular nucleic acid vectors, and methods for making and using the same Apr 3, 2006 Issued
Array ( [id] => 8591680 [patent_doc_number] => 08349555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures' [patent_app_type] => utility [patent_app_number] => 11/908775 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 23218 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11908775 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908775
Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures Mar 15, 2006 Issued
Array ( [id] => 4921934 [patent_doc_number] => 20080070249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Novel Activating Agent of Glucose Uptake and a Screening Method Therefor' [patent_app_type] => utility [patent_app_number] => 11/663194 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8199 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070249.pdf [firstpage_image] =>[orig_patent_app_number] => 11663194 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663194
Novel Activating Agent of Glucose Uptake and a Screening Method Therefor Mar 13, 2006 Abandoned
Array ( [id] => 4893425 [patent_doc_number] => 20080102523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Expression Vector for Animal Cell Comprising at Least One Copy of Mar Dna Sequences at the 3\'Terminal of Transcription Termination Region of a Gene and Method for the Expression of Foreign Gene Using the Vector' [patent_app_type] => utility [patent_app_number] => 11/817756 [patent_app_country] => US [patent_app_date] => 2006-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7107 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102523.pdf [firstpage_image] =>[orig_patent_app_number] => 11817756 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817756
Expression vector for animal cell comprising at least one copy of MAR DNA sequences at the 3′ terminal of transcription termination region of a gene and method for the expression of foreign gene using the vector Mar 3, 2006 Issued
Array ( [id] => 5608054 [patent_doc_number] => 20060269570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Recombinant double-stranded RNA phage, and use of the same' [patent_app_type] => utility [patent_app_number] => 11/361007 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17456 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269570.pdf [firstpage_image] =>[orig_patent_app_number] => 11361007 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/361007
Recombinant double-stranded RNA phage, and use of the same Feb 23, 2006 Issued
Array ( [id] => 5732250 [patent_doc_number] => 20060257367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Tumour-cell specific gene expression and its use in cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/352053 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10289 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257367.pdf [firstpage_image] =>[orig_patent_app_number] => 11352053 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/352053
Tumour-cell specific gene expression and its use in cancer therapy Feb 9, 2006 Abandoned
Array ( [id] => 5874154 [patent_doc_number] => 20060166251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Use of sFRPs as markers of BMP activity' [patent_app_type] => utility [patent_app_number] => 11/339549 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8192 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166251.pdf [firstpage_image] =>[orig_patent_app_number] => 11339549 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/339549
Use of sFRPs as markers of BMP activity Jan 25, 2006 Abandoned
Array ( [id] => 5705182 [patent_doc_number] => 20060194230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Genetic markers associated with benign prostatic hyperplasia' [patent_app_type] => utility [patent_app_number] => 11/339733 [patent_app_country] => US [patent_app_date] => 2006-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24936 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194230.pdf [firstpage_image] =>[orig_patent_app_number] => 11339733 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/339733
Genetic markers associated with benign prostatic hyperplasia Jan 24, 2006 Abandoned
Array ( [id] => 5062956 [patent_doc_number] => 20070224596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Compositions and methods for the modifying hypoxia induced gene regulation' [patent_app_type] => utility [patent_app_number] => 11/247103 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 79334 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224596.pdf [firstpage_image] =>[orig_patent_app_number] => 11247103 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/247103
Compositions and methods for the modifying hypoxia induced gene regulation Jan 19, 2006 Abandoned
Array ( [id] => 5753480 [patent_doc_number] => 20060222629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Compositions and methods for delivery of genetic material' [patent_app_type] => utility [patent_app_number] => 11/317548 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30431 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20060222629.pdf [firstpage_image] =>[orig_patent_app_number] => 11317548 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/317548
Compositions and methods for delivery of genetic material Dec 22, 2005 Issued
Array ( [id] => 8446034 [patent_doc_number] => 08288085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Method of separating pancreatic islet' [patent_app_type] => utility [patent_app_number] => 11/793679 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 12516 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11793679 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793679
Method of separating pancreatic islet Dec 21, 2005 Issued
Array ( [id] => 9970959 [patent_doc_number] => 09017965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Hybrid 3′ untranslated regions suitable for efficient protein expression in mammalian cells' [patent_app_type] => utility [patent_app_number] => 12/097169 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6992 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12097169 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/097169
Hybrid 3′ untranslated regions suitable for efficient protein expression in mammalian cells Dec 11, 2005 Issued
Array ( [id] => 5649046 [patent_doc_number] => 20060134781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Three-dimensional cell culture system' [patent_app_type] => utility [patent_app_number] => 11/296802 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12094 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134781.pdf [firstpage_image] =>[orig_patent_app_number] => 11296802 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/296802
Three-dimensional cell culture system Dec 6, 2005 Abandoned
Array ( [id] => 5661460 [patent_doc_number] => 20060252056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Markers for responsiveness to an erbB receptor tyrosine kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 11/290173 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26061 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252056.pdf [firstpage_image] =>[orig_patent_app_number] => 11290173 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/290173
Markers for responsiveness to an erbB receptor tyrosine kinase inhibitor Nov 29, 2005 Abandoned
Array ( [id] => 5815268 [patent_doc_number] => 20060084798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use' [patent_app_type] => utility [patent_app_number] => 11/288720 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22128 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084798.pdf [firstpage_image] =>[orig_patent_app_number] => 11288720 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/288720
cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use Nov 28, 2005 Issued
Array ( [id] => 5655769 [patent_doc_number] => 20060141504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Molecular technologies for improved risk classification and therapy for acute lymphoblastic leukemia in children and adults' [patent_app_type] => utility [patent_app_number] => 11/285976 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17979 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141504.pdf [firstpage_image] =>[orig_patent_app_number] => 11285976 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/285976
Molecular technologies for improved risk classification and therapy for acute lymphoblastic leukemia in children and adults Nov 22, 2005 Abandoned
Menu